Eplerenone for treatment of chronic central serous chorioretinopathy.

Doris Fraenkel Shady SuffoAchim LangenbucherBerthold SeitzAlaa Din Abdin

Published in: European journal of ophthalmology (2020)

This study showed a statistically significant improvement of the best corrected visual acuity and a significant reduction of macular thickness and subretinal fluid in patients with chronic CSC treated with oral eplerenone, especially in patients under stress.

Keyphrases

newly diagnosed
optical coherence tomography
end stage renal disease
ejection fraction
high grade
prognostic factors
diabetic retinopathy
combination therapy
cataract surgery